366 related articles for article (PubMed ID: 31954513)
1. Nobiletin, a novel inhibitor, inhibits HBsAg production and hepatitis B virus replication.
Hu Z; Hu J; Ren F; Xu H; Tan M; Wang Q; Ren J
Biochem Biophys Res Commun; 2020 Mar; 523(3):802-808. PubMed ID: 31954513
[TBL] [Abstract][Full Text] [Related]
2. Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg production.
Ren F; Yang X; Hu ZW; Wong VKW; Xu HY; Ren JH; Zhong S; Jia XJ; Jiang H; Hu JL; Cai XF; Zhang WL; Yao FL; Yu HB; Cheng ST; Zhou HZ; Huang AL; Law BYK; Chen J
EBioMedicine; 2019 Nov; 49():232-246. PubMed ID: 31680002
[TBL] [Abstract][Full Text] [Related]
3. Anti-HBV therapeutic potential of small molecule 3,5,6,7,3',4'-Hexamethoxyflavone in vitro and in vivo.
Tan M; Ren F; Yang X
Virology; 2021 Aug; 560():66-75. PubMed ID: 34051476
[TBL] [Abstract][Full Text] [Related]
4. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
Liu Y; Yao W; Si L; Hou J; Wang J; Xu Z; Li W; Chen J; Li R; Li P; Bo L; Xiao X; Lan J; Xu D
Antiviral Res; 2018 Jul; 155():39-47. PubMed ID: 29702120
[TBL] [Abstract][Full Text] [Related]
5. Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.
Zhao Z; Hong W; Zeng Z; Wu Y; Hu K; Tian X; Li W; Cao Z
J Biol Chem; 2012 Aug; 287(36):30181-90. PubMed ID: 22791717
[TBL] [Abstract][Full Text] [Related]
6. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
Tsuge M; Uchida T; Hiraga N; Kan H; Makokha GN; Abe-Chayama H; Miki D; Imamura M; Ochi H; Hayes CN; Shimozono R; Iwamura T; Narumi H; Suzuki T; Kainoh M; Taniguchi T; Chayama K
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373196
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells.
Xun YH; Zhang YJ; Pan QC; Mao RC; Qin YL; Liu HY; Zhang YM; Yu YS; Tang ZH; Lu MJ; Zang GQ; Zhang JM
J Viral Hepat; 2014 Aug; 21(8):597-603. PubMed ID: 24164660
[TBL] [Abstract][Full Text] [Related]
8. Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription.
Ren F; Zhao S; He X; Lo H; Wong VKW; Law BYK; Wu A; Zhang J
J Med Virol; 2024 May; 96(5):e29669. PubMed ID: 38773784
[TBL] [Abstract][Full Text] [Related]
9. Anti-hepatitis B virus activity of swertisin isolated from Iris tectorum Maxim.
Xu HY; Ren JH; Su Y; Ren F; Zhou YJ; Jiang H; Cheng ST; Zhang CR; Chen J
J Ethnopharmacol; 2020 Jul; 257():112787. PubMed ID: 32224198
[TBL] [Abstract][Full Text] [Related]
10. The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice.
Gallay P; Ure D; Bobardt M; Chatterji U; Ou J; Trepanier D; Foster R
PLoS One; 2019; 14(6):e0217433. PubMed ID: 31181107
[TBL] [Abstract][Full Text] [Related]
11. A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro.
Zeng Z; Zhang Q; Hong W; Xie Y; Liu Y; Li W; Wu Y; Cao Z
Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27128943
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice.
Lai YH; Sun CP; Huang HC; Chen JC; Liu HK; Huang C
BMC Complement Altern Med; 2018 Sep; 18(1):248. PubMed ID: 30189898
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Activity of Cananga odorata Against Hepatitis B Virus.
Indrasetiawan P; Aoki-Utsubo C; Hanafi M; Hartati S; Wahyuni TS; Kameoka M; Yano Y; Hotta H; Hayashi Y
Kobe J Med Sci; 2019 Nov; 65(2):E71-E79. PubMed ID: 31956259
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
Yang Q; Zhao X; Zang L; Fang X; Zhao J; Yang X; Wang Q; Zheng L; Chang J
Antiviral Res; 2012 Dec; 96(3):333-9. PubMed ID: 23098744
[TBL] [Abstract][Full Text] [Related]
15. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
Wong DK; Seto WK; Fung J; Ip P; Huang FY; Lai CL; Yuen MF
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1004-10.e1. PubMed ID: 23376799
[TBL] [Abstract][Full Text] [Related]
16. Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production.
Phillips S; Chokshi S; Chatterji U; Riva A; Bobardt M; Williams R; Gallay P; Naoumov NV
Gastroenterology; 2015 Feb; 148(2):403-14.e7. PubMed ID: 25305505
[TBL] [Abstract][Full Text] [Related]
17. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
18. Antiviral effects of a niobium-substituted heteropolytungstate on hepatitis B virus-transgenic mice.
Li Q; Zhang H; Qi Y; Wang J; Li J; Niu J
Drug Dev Res; 2019 Dec; 80(8):1062-1070. PubMed ID: 31396981
[TBL] [Abstract][Full Text] [Related]
19. A peptide-based inhibitor of gp96 suppresses HBsAg expression and HBV replication by upregulation of p53.
Qian L; Fan H; Ju Y; Chen L; Li X; Ye X; Luo Y; Li C; Meng S
J Gen Virol; 2019 Aug; 100(8):1241-1252. PubMed ID: 31204972
[TBL] [Abstract][Full Text] [Related]
20. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
